Posted by bearfan on January 25, 2011, at 16:22:37
In reply to Re: New FDA Approval for MDD Viibyrd (Vilazodone), posted by linkadge on January 23, 2011, at 15:35:43
I audited a presentation from Clincial Data and big name investors (WeedBush etc.). The folks at Clinical Data seemed very happy (almost elated) at the potential of this drug. From the conversation, a big strong point was the tolerability with lack of cardio and hepatic side effects. Weight gain and sexual dysfunction was also not apparent. My guess is the efficacy is near or possibly lower than some existing treatments, but can be useful for patients in a more stable period who wish to drop side effects for a medicine less strong. Cymbalta and Lexapro go off-patent in a year or two and the new approval will give it patent protection for quite some time.
poster:bearfan
thread:977653
URL: http://www.dr-bob.org/babble/20110115/msgs/977946.html